Implications of Ozempic and Other GLP-1 Receptor Agonists for Facial Plastic Surgeons
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Obesity is a growing global health concern. Glucagon-like peptide-1 (GLP-1) receptor agonists, such as Ozempic, have emerged as potential treatments. GLP-1 receptor agonists regulate appetite and can promote weight loss. Some GLP-1 receptor agonists, though Food and Drug Administration (FDA)-approved for diabetes, are also used off-label for weight loss alone. Rapid weight and fat loss with these medications can lead to what has been called “Ozempic Face” on social media and in the lay press, where facial volume and fat are depleted, resulting in wrinkles and sagging skin. Prescribers rarely counsel patients about the potential impact on the face, and the plastic surgery community faces a challenge in managing the facial changes associated with rapid weight loss. Dermal fillers, skin tightening techniques, and surgical interventions are useful for both restoration of facial volume and to manage excess skin. Discontinuation of GLP-1 receptor agonists should be considered prior to general anesthesia due to delayed gastric emptying while on these medications. As the popularity of GLP-1 receptor agonists grows, facial plastic surgeons must be aware of both the impact on facial appearance and perioperative considerations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Once-Weekly Semaglutide in Adults with Overweight or Obesity
Wilding, J. P. H., Batterham, R. L., Calanna, S., Davies, M., Van Gaal, L. F., Lingvay, I., McGowan, B. M., Rosenstock, J., Tran, M. T. D., Wadden, T. A., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2032183 · Cited by 5,205
Research works printed but not linked: 5
- M Suran, 2023, As Ozempic's popularity soars, here's what to know about semaglutide and weight loss, JAMA, 329, 1627, 10.1001/jama.2023.2438 · DOI · Paper page
- D Rubino, 2021, Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance in adults with overweight or obesity: the STEP 4 randomized clinical trial, JAMA, 325, 1414, 10.1001/jama.2021.3224 · DOI · Paper page
- R A Couto, 2015, Objective assessment of facial rejuvenation after massive weight loss, Aesthetic Plast Surg, 39, 847, 10.1007/s00266-015-0540-6 · DOI
- R A Couto, 2019, Facelift in patients with massive weight loss, Clin Plast Surg, 46, 559, 10.1016/j.cps.2019.05.003 · DOI
- E Harris, 2023, Oral semaglutide led to similar weight loss as injection, company says, JAMA, 329, 2011, 10.1001/jama.2023.9601 · DOI
Cited by
Weight Reduction with GLP-1 Agonists and Paths for Discontinuation While Maintaining Weight Loss
Reiss, A. B., Gulkarov, S., Lau, R., Klek, S. P., Srivastava, A., Renna, H. A., & De Leon, J. (2025) · Biomolecules · doi:10.3390/biom15030408 · Cited by 58
“The rapid weight loss can be visualized in many areas of the body and one of these manifestations known as “Ozempic face” occurs when fat pads in the face are rapidly depleted [177,178].”
O’Neill, E. S., Wiegmann, A. L., Parrella, N., Pittman, T., Hood, K., & Kurlander, D. (2024) · Plastic and Reconstructive Surgery - Global Open · doi:10.1097/gox.0000000000005516 · Cited by 43
“45 Plastic surgeons have many options at their disposal to help combat these changes to facial morphology.”
BackgroundRecent advances in peptide-based therapies for obesity and type 2 diabetes
Bailey, C. J., Flatt, P. R., & Conlon, J. M. (2024) · Peptides · doi:10.1016/j.peptides.2024.171149 · Cited by 25
Metadata
- Authors
- Humphrey, C. D., & Lawrence, A. C.
- Venue
- Facial Plastic Surgery
- Publisher
- Georg Thieme Verlag KG
- Published
- 2023-08-04
- Volume
- 39
- Issue
- 06
- Pages
- 719-721
- ISSN
- 0736-6825 (ISSN-L)
- 1098-8793
- OpenAlex
- W4385566892
- Cited by
- 77
- References
- 1
- FWCI
- 17.50
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Implications of Ozempic and Other GLP-1 Receptor Agonists for Facial Plastic Surgeons. https://app.cochat.ai/papers/10.1055/a-2148-6321
- The paper
- Humphrey, C. D., & Lawrence, A. C. (2023). Implications of Ozempic and Other GLP-1 Receptor Agonists for Facial Plastic Surgeons. Facial Plastic Surgery. https://doi.org/10.1055/a-2148-6321
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.